TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Interactive Exoskeleton Robot for Walking - Ankle Joint
Brief Summary: A novel interactive exoskeleton robotic system with embedded force and motion sensors will be developed to facilitate walking of stroke patients with hemiparesis. The robot will synchronise with the gait pattern of the stroke patient to provide assistance in ankle dorsiflexion during swing phase. It is hypothesised that the robot can facilitate stable and longer walking distance for stroke patients with drop foot problem. It can be applied on unilateral side, which is suitable for stroke patients with hemiparesis. The whole system design is lightweight, compact, comfortable, and user-friendly in hospital or at home settings.


Options:
A: Arm Label: Samsung Hip Assist v1; Type: EXPERIMENTAL; Interventions: Device: gait rehabilitation with Samsung Hip Assist v1 | Arm Label: Conventional gait training; Type: ACTIVE_COMPARATOR; Interventions: Other: gait rehabilitation without Samsung Hip Assist v1 | Intervention Type: DEVICE; Name: gait rehabilitation with Samsung Hip Assist v1; Assigned to Arm(s): Samsung Hip Assist v1 | Intervention Type: OTHER; Name: gait rehabilitation without Samsung Hip Assist v1; Assigned to Arm(s): Conventional gait training
B: Arm Label: Robot, then conventional training; Type: EXPERIMENTAL; Interventions: Other: Robot, then conventional training | Arm Label: Conventional, then robot training; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional, then robot training | Intervention Type: OTHER; Name: Robot, then conventional training; Assigned to Arm(s): Robot, then conventional training | Intervention Type: OTHER; Name: Conventional, then robot training; Assigned to Arm(s): Conventional, then robot training
C: Arm Label: Exoskeleton Program; Type: EXPERIMENTAL; Interventions: Device: Exoskeleton Program | Arm Label: Usual Care Program; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care Program | Intervention Type: DEVICE; Name: Exoskeleton Program; Assigned to Arm(s): Exoskeleton Program | Intervention Type: OTHER; Name: Usual Care Program; Assigned to Arm(s): Usual Care Program
D: Arm Label: Ankle Robot with Power Assistance; Type: EXPERIMENTAL; Interventions: Device: Ankle Robot with Power Assistance | Arm Label: Sham group; Type: PLACEBO_COMPARATOR; Interventions: Device: Sham | Intervention Type: DEVICE; Name: Ankle Robot with Power Assistance; Assigned to Arm(s): Ankle Robot with Power Assistance | Intervention Type: DEVICE; Name: Sham; Assigned to Arm(s): Sham group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of a Freeze All Protocol Versus Fresh Embryo Transfer in Women Undergoing In-vitro Fertilization (IVF) - Intracytoplasmic Sperm Injection (ICSI)
Brief Summary: To compare the effectiveness of freeze-all and subsequent frozen embryo transfer (freeze all protocol) with fresh embryo transfer (fresh ET).


Options:
A: Arm Label: Provera; Type: EXPERIMENTAL; Interventions: Drug: Provera 10 mg. | Arm Label: Orgalutrán Ganirelix (GnRH antagonist); Type: ACTIVE_COMPARATOR; Interventions: Drug: Ganirelix (GnRH antagonist) | Intervention Type: DRUG; Name: Provera 10 mg.; Assigned to Arm(s): Provera | Intervention Type: DRUG; Name: Ganirelix (GnRH antagonist); Assigned to Arm(s): Orgalutrán Ganirelix (GnRH antagonist)
B: Arm Label: fresh embryo transfer group; Type: EXPERIMENTAL; Interventions: Other: fresh embryo transfer | Arm Label: frozen-thawed embryo transfer group; Type: EXPERIMENTAL; Interventions: Other: frozen-thawed embryo transfer | Intervention Type: OTHER; Name: fresh embryo transfer; Assigned to Arm(s): fresh embryo transfer group | Intervention Type: OTHER; Name: frozen-thawed embryo transfer; Assigned to Arm(s): frozen-thawed embryo transfer group
C: Arm Label: Progevera; Type: EXPERIMENTAL; Interventions: Drug: Progevera | Arm Label: Orgalutran; Type: ACTIVE_COMPARATOR; Interventions: Drug: Orgalutran | Intervention Type: DRUG; Name: Progevera; Assigned to Arm(s): Progevera | Intervention Type: DRUG; Name: Orgalutran; Assigned to Arm(s): Orgalutran
D: Arm Label: Freeze-all protocol; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Freeze-all protocol | Arm Label: Fresh transfer protocol; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Fresh transfer protocol | Intervention Type: PROCEDURE; Name: Freeze-all protocol; Assigned to Arm(s): Freeze-all protocol | Intervention Type: PROCEDURE; Name: Fresh transfer protocol; Assigned to Arm(s): Fresh transfer protocol

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of a Freeze All Protocol Versus Fresh Embryo Transfer in Women Undergoing In-vitro Fertilization (IVF) - Intracytoplasmic Sperm Injection (ICSI)
Brief Summary: To compare the effectiveness of freeze-all and subsequent frozen embryo transfer (freeze all protocol) with fresh embryo transfer (fresh ET).


Options:
A: Arm Label: Freeze all; Type: EXPERIMENTAL; Interventions: Procedure: Freeze all | Arm Label: Fresh embryo transfer; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Freeze all; Assigned to Arm(s): Freeze all
B: Arm Label: Blastocyst transfer in PTEC cycle; Type: EXPERIMENTAL; Interventions: Procedure: Embryo cryopreservation | Arm Label: Fresh blastocyst transfer.; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Fresh blastocyst transfer | Intervention Type: PROCEDURE; Name: Embryo cryopreservation; Assigned to Arm(s): Blastocyst transfer in PTEC cycle | Intervention Type: PROCEDURE; Name: Fresh blastocyst transfer; Assigned to Arm(s): Fresh blastocyst transfer.
C: Arm Label: Freeze-all protocol; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Freeze-all protocol | Arm Label: Fresh transfer protocol; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Fresh transfer protocol | Intervention Type: PROCEDURE; Name: Freeze-all protocol; Assigned to Arm(s): Freeze-all protocol | Intervention Type: PROCEDURE; Name: Fresh transfer protocol; Assigned to Arm(s): Fresh transfer protocol
D: Arm Label: Frozen Embryo Transfer with PGD; Type: EXPERIMENTAL; Interventions: Other: PGD | Arm Label: Fresh Embryo Transfer with PGD; Type: EXPERIMENTAL; Interventions: Other: PGD | Intervention Type: OTHER; Name: PGD; Assigned to Arm(s): Fresh Embryo Transfer with PGD, Frozen Embryo Transfer with PGD

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of a Freeze All Protocol Versus Fresh Embryo Transfer in Women Undergoing In-vitro Fertilization (IVF) - Intracytoplasmic Sperm Injection (ICSI)
Brief Summary: To compare the effectiveness of freeze-all and subsequent frozen embryo transfer (freeze all protocol) with fresh embryo transfer (fresh ET).


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Intensified luteal phase support for fresh embryo transfer, Drug: Pregnyl®, Drug: Utrogestan®, Drug: Progynova® | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Procedure: Vitrification with subsequent-cycle embryo thawing/transfer, Device: CryoBioSystem® | Intervention Type: PROCEDURE; Name: Vitrification with subsequent-cycle embryo thawing/transfer; Assigned to Arm(s): Intervention | Intervention Type: PROCEDURE; Name: Intensified luteal phase support for fresh embryo transfer; Assigned to Arm(s): Control | Intervention Type: DRUG; Name: Pregnyl®; Assigned to Arm(s): Control | Intervention Type: DRUG; Name: Utrogestan®; Assigned to Arm(s): Control | Intervention Type: DRUG; Name: Progynova®; Assigned to Arm(s): Control | Intervention Type: DEVICE; Name: CryoBioSystem®; Assigned to Arm(s): Intervention
B: Arm Label: Freeze-all protocol; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Freeze-all protocol | Arm Label: Fresh transfer protocol; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Fresh transfer protocol | Intervention Type: PROCEDURE; Name: Freeze-all protocol; Assigned to Arm(s): Freeze-all protocol | Intervention Type: PROCEDURE; Name: Fresh transfer protocol; Assigned to Arm(s): Fresh transfer protocol
C: Arm Label: frozen-embryo transfer; Type: ACTIVE_COMPARATOR; Interventions: Procedure: freezing embryos by vitrification, Drug: buserelin, Drug: recombinant FSH, Drug: human chorionic gonadotropin (pregnyl) | Arm Label: fresh embryo transfer; Type: ACTIVE_COMPARATOR; Interventions: Procedure: fresh embryo transfers, Drug: buserelin, Drug: recombinant FSH, Drug: human chorionic gonadotropin (pregnyl) | Intervention Type: PROCEDURE; Name: freezing embryos by vitrification; Assigned to Arm(s): frozen-embryo transfer | Intervention Type: PROCEDURE; Name: fresh embryo transfers; Assigned to Arm(s): fresh embryo transfer | Intervention Type: DRUG; Name: buserelin; Assigned to Arm(s): fresh embryo transfer, frozen-embryo transfer | Intervention Type: DRUG; Name: recombinant FSH; Assigned to Arm(s): fresh embryo transfer, frozen-embryo transfer | Intervention Type: DRUG; Name: human chorionic gonadotropin (pregnyl); Assigned to Arm(s): fresh embryo transfer, frozen-embryo transfer
D: Arm Label: Frozen Embryo Transfer with PGD; Type: EXPERIMENTAL; Interventions: Other: PGD | Arm Label: Fresh Embryo Transfer with PGD; Type: EXPERIMENTAL; Interventions: Other: PGD | Intervention Type: OTHER; Name: PGD; Assigned to Arm(s): Fresh Embryo Transfer with PGD, Frozen Embryo Transfer with PGD

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dementia in Long Term Care Facilities: Telemedicine for the Management of Neuropsychiatric Symptoms.
Brief Summary: Telemedicine may facilitate adequate treatment of Neuropsychiatric symptoms (NPS) by identifying underlying causes and tailoring a treatment plan (pharmacological or non-pharmacologic treatments including provision of staff education and support, training in problem solving, and targeted therapy directed at the underlying causes for specific behaviors).


Options:
A: Arm Label: Advance Care Planning Program; Type: EXPERIMENTAL; Interventions: Other: Implementation of a complex regional Advance Care Planning program | Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Implementation of a complex regional Advance Care Planning program; Assigned to Arm(s): Advance Care Planning Program
B: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: ACTIVE; Type: EXPERIMENTAL; Interventions: Behavioral: ACTIVE | Intervention Type: BEHAVIORAL; Name: ACTIVE; Assigned to Arm(s): ACTIVE
C: Arm Label: normal care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: telemedicine; Type: EXPERIMENTAL; Interventions: Procedure: telemedicine | Intervention Type: PROCEDURE; Name: telemedicine; Assigned to Arm(s): telemedicine
D: Arm Label: Intervention; Type: OTHER; Interventions: Procedure: a clinical pathway nursing home acquired pneumonia | Arm Label: Comparator; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: a clinical pathway nursing home acquired pneumonia; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Lymphocytic Enteritis and Suspected Coeliac Disease: Double-blind Gluten vs Placebo Rechallenge
Brief Summary: Patients with lymphocytic enteritis (LE), HLA-DQ2/8+, negative celiac serology and clinical and histological response to a gluten-free diet (GFD) do not fulfil the diagnostic criteria of coeliac disease (CoD). At present it remains unclear whether they suffer from coeliac gluten sensitivity (CGS) or non-coeliac gluten sensitivity (NCGS). There are specific tissue markers of CoD such as anti-transglutaminase deposits (tTG) and intraepithelial lymphocytes expressing T-cell receptor (TCR) gamma/delta+.

Aim: To demonstrate the existence of CGS in these patients despite having negative celiac serology.

Methods: Double-blind randomized clinical trial of gluten vs placebo rechallenge for 6 months in patients with LE on a GFD. Inclusion criteria: \>18 years, initial presentation with GI symptoms, HLA-DQ2/8+, negative celiac serology, good clinical and histological response to GFD. Patients were randomised to gluten (20 g/day) and placebo (maltrodextrin) (identical powder sachets mixed with meals). Clinical symptoms were analysed using visual analogue scales. Quality of life (GIQLI), adherence to diet, serology, and histological changes including gamma/delta+ IEL and tTG deposits were evaluated.


Options:
A: Arm Label: Group 1; Type: EXPERIMENTAL; Interventions: Other: Normal gluten containing bread | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Other: Bread with reduced gliadins content | Arm Label: Group 3; Type: EXPERIMENTAL; Interventions: Other: Bread with reduced ATIs content | Arm Label: Group 4; Type: EXPERIMENTAL; Interventions: Other: Bread with reduced overall protein content | Intervention Type: OTHER; Name: Normal gluten containing bread; Assigned to Arm(s): Group 1 | Intervention Type: OTHER; Name: Bread with reduced gliadins content; Assigned to Arm(s): Group 2 | Intervention Type: OTHER; Name: Bread with reduced ATIs content; Assigned to Arm(s): Group 3 | Intervention Type: OTHER; Name: Bread with reduced overall protein content; Assigned to Arm(s): Group 4
B: Arm Label: Gluten-free diet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Gluten-free diet | Intervention Type: DIETARY_SUPPLEMENT; Name: Gluten-free diet; Assigned to Arm(s): Gluten-free diet
C: Arm Label: Gluten challenge; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Gluten challenge | Arm Label: Placebo challenge; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo challenge | Intervention Type: DIETARY_SUPPLEMENT; Name: Gluten challenge; Assigned to Arm(s): Gluten challenge | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo challenge; Assigned to Arm(s): Placebo challenge
D: Arm Label: gluten-containing diet; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Active comparator, gluten-free diet; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Gluten-free diet | Intervention Type: DIETARY_SUPPLEMENT; Name: Gluten-free diet; Assigned to Arm(s): Active comparator, gluten-free diet

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: MarrOwStim™ PAD Kit for the Treatment of Critical LimB IschemIa (CLI) in Subjects With Severe Peripheral ArteriaL DiseasE (PAD) (MOBILE) - Continued Access
Brief Summary: This study will continue to evaluate the performance of the MarrowStim™ PAD Kit to treat subjects with critical limb ischemia (CLI) caused by severe PAD.


Options:
A: Intervention Type: GENETIC; Name: Autologous peripheral blood CD34 positive cell therapy; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: intraarterial stem cell therapy, Other: Stem cells | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Procedure: intraarterial stem cell therapy, Other: Stem cells | Intervention Type: PROCEDURE; Name: intraarterial stem cell therapy; Assigned to Arm(s): 1, 2 | Intervention Type: OTHER; Name: Stem cells; Assigned to Arm(s): 1, 2
C: Intervention Type: DEVICE; Name: Bone marrow concentration device; Assigned to Arm(s): N/A
D: Arm Label: mesenchymal stem cells; Type: EXPERIMENTAL; Interventions: Drug: mesenchymal stem cells | Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Plasmalyte A | Intervention Type: DRUG; Name: mesenchymal stem cells; Assigned to Arm(s): mesenchymal stem cells | Intervention Type: DRUG; Name: Plasmalyte A; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: MarrOwStim™ PAD Kit for the Treatment of Critical LimB IschemIa (CLI) in Subjects With Severe Peripheral ArteriaL DiseasE (PAD) (MOBILE) - Continued Access
Brief Summary: This study will continue to evaluate the performance of the MarrowStim™ PAD Kit to treat subjects with critical limb ischemia (CLI) caused by severe PAD.


Options:
A: Arm Label: Active/Treatment Group; Type: EXPERIMENTAL; Interventions: Biological: Allogeneic bone marrow derived mesenchymal stem cells | Arm Label: Observation Group 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Observation Group 2; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Observation Group 3; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control Group 4; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: Allogeneic bone marrow derived mesenchymal stem cells; Assigned to Arm(s): Active/Treatment Group
B: Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: bone marrow stem cells intraarterial; Type: ACTIVE_COMPARATOR; Interventions: Biological: bone marrow stem cells (BMC) | Arm Label: tissue repair cells intramuscular; Type: ACTIVE_COMPARATOR; Interventions: Biological: tissue repair cells (TRC) | Arm Label: tissue repair cells intraarterial; Type: ACTIVE_COMPARATOR; Interventions: Biological: tissue repair cells (TRC) | Arm Label: bone marrow stem cells intramuscular; Type: ACTIVE_COMPARATOR; Interventions: Biological: bone marrow stem cells (BMC) | Intervention Type: BIOLOGICAL; Name: tissue repair cells (TRC); Assigned to Arm(s): tissue repair cells intraarterial, tissue repair cells intramuscular | Intervention Type: BIOLOGICAL; Name: bone marrow stem cells (BMC); Assigned to Arm(s): bone marrow stem cells intraarterial, bone marrow stem cells intramuscular
C: Intervention Type: DEVICE; Name: Bone marrow concentration device; Assigned to Arm(s): N/A
D: Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: ALDH-br bone marrow cells vs. mononuclear bone marrow cells | Intervention Type: PROCEDURE; Name: ALDH-br bone marrow cells vs. mononuclear bone marrow cells; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical, Biochemical and Neurophysiological Consequences of Intraoperative
Brief Summary: Clinical, Biochemical and Neurophysiological Consequences of Intraoperative Tourniquet During Total Knee Arthroplasty:

WOMAC-Score Knee-Score Radiographic Evaluations and Scoring System Biochemical muscle biopsy analysis


Options:
A: Arm Label: Aquamantys; Type: EXPERIMENTAL; Interventions: Device: Aquamantys | Arm Label: Standard of Care: Tourniquet; Type: ACTIVE_COMPARATOR; Interventions: Device: Tourniquet | Intervention Type: DEVICE; Name: Aquamantys; Assigned to Arm(s): Aquamantys | Intervention Type: DEVICE; Name: Tourniquet; Assigned to Arm(s): Standard of Care: Tourniquet
B: Arm Label: treatment; Type: EXPERIMENTAL; Interventions: Drug: General Anesthesia | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Neuraxial anesthesia | Intervention Type: DRUG; Name: General Anesthesia; Assigned to Arm(s): treatment | Intervention Type: DRUG; Name: Neuraxial anesthesia; Assigned to Arm(s): Placebo
C: Arm Label: Tourniquet; Type: EXPERIMENTAL; Interventions: Device: Tourniquet | Arm Label: No tourniquet; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Tourniquet; Assigned to Arm(s): Tourniquet
D: Arm Label: tourniquet; Type: EXPERIMENTAL; Interventions: Procedure: Total knee arthroplasty | Arm Label: non-tourniquet; Type: EXPERIMENTAL; Interventions: Procedure: Total knee arthroplasty | Intervention Type: PROCEDURE; Name: Total knee arthroplasty; Assigned to Arm(s): non-tourniquet, tourniquet

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial of a Multifactorial Fall Injury Prevention Strategy
Brief Summary: The aim of this pragmatic cluster-randomized trial is to determine the effectiveness of an evidence-based, patient-centered multifactorial fall injury prevention strategy in community dwelling older adults at risk of falls recruited from 86 primary care practices around the U.S.


Options:
A: Arm Label: DESTRESS-WV; Type: EXPERIMENTAL; Interventions: Behavioral: DESTRESS-WV | Arm Label: Phone Monitoring; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Phone Monitoring | Intervention Type: BEHAVIORAL; Name: DESTRESS-WV; Assigned to Arm(s): DESTRESS-WV | Intervention Type: BEHAVIORAL; Name: Phone Monitoring; Assigned to Arm(s): Phone Monitoring
B: Arm Label: Cognitive behavioural therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive behavioural therapy | Arm Label: Tai chi; Type: ACTIVE_COMPARATOR; Interventions: Other: Tai chi | Arm Label: Postural control exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: Postural control exercise | Intervention Type: BEHAVIORAL; Name: Cognitive behavioural therapy; Assigned to Arm(s): Cognitive behavioural therapy | Intervention Type: OTHER; Name: Tai chi; Assigned to Arm(s): Tai chi | Intervention Type: OTHER; Name: Postural control exercise; Assigned to Arm(s): Postural control exercise
C: Arm Label: Education about falls; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fall prevention education | Arm Label: Activity, Balance, Learning, and Exposure; Type: EXPERIMENTAL; Interventions: Behavioral: Activity, Balance, Learning, and Exposure | Intervention Type: BEHAVIORAL; Name: Activity, Balance, Learning, and Exposure; Assigned to Arm(s): Activity, Balance, Learning, and Exposure | Intervention Type: BEHAVIORAL; Name: Fall prevention education; Assigned to Arm(s): Education about falls
D: Arm Label: Fall prevention standard of care; Type: OTHER; Interventions: Other: Evidence-based tailored fall prevention | Arm Label: Control; Type: OTHER; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Evidence-based tailored fall prevention; Assigned to Arm(s): Fall prevention standard of care | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Control

Answer: D